rapid develop resist antifol vitro possibl clinic implic incub period methotrex mtx trimetrex tmtx human colon adenocarcinoma cell high level resist drug increas median effect dose short-term exposur hour drug high degre resist cell treatment cycl mtx tmtx onset resist antimetabolit cell strategi result mtx tmtx mice murin leukemia cell cell resist short-term exposur mtx cross-resist drug day cell mtx day cross-resist drug hour analog result tmtx circumst schedul administr agent resist clinic relev data adjuv chemotherapi loco-region continuous-infus chemotherapi 